DIAMOX Tablet

Active ingredients: Acetazolamide

Product name and form

DIAMOX 250mg Tablets.

Acetazolamide Mercury Pharma 250mg Tablets.

Pharmaceutical Form

Tablet.

Round, convex, white tablets engraved with “FW 147” on one side and cored in quarters on the other.

Qualitative and quantitative composition

Each tablet contains 250mg acetazolamide BP.

For excipients see 6.1.

Active Ingredient
Description

Acetazolamide is an enzyme inhibitor which acts specifically on carbonic anhydrase. By inhibiting the reaction catalysed by this enzyme in the renal tubules, acetazolamide increases the excretion of bicarbonate and of cations, chiefly sodium and potassium, and so promotes alkaline diuresis. By inhibiting carbonic anhydrase in the eye acetazolamide decreases intra-ocular pressure and is therefore useful in the treatment of glaucoma.

List of Excipients

Dicalcium phosphate
Corn starch
Magnesium stearate
Sodium starch glycolate
Povidone

Pack sizes and marketing

Amber glass bottles with metal screw-on caps.

Polypropylene bottles with plastic screw-on caps.

The product is supplied in bottles of 112 tablets.

Marketing authorization holder

Mercury Pharmaceuticals Ltd, Capital House, 85 King William Street, London EC4N 7BL, UK

Marketing authorization dates and numbers

PL 12762/0147

12/12/2003

Drugs

Drug
Countries
Austria, Australia, Brazil, France, Ireland, Netherlands, United Kingdom